REPORT ID 4075

Global Indoleamine 2,3 Dioxygenase 1 Sales Market Report 2017

Publish Date
15-Dec-17
Pages
117
Format
Electronic (PDF)

In this report, the global Indoleamine 2,3 Dioxygenase 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Indoleamine 2,3 Dioxygenase 1 for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Indoleamine 2,3 Dioxygenase 1 market competition by top manufacturers/players, with Indoleamine 2,3 Dioxygenase 1 sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    BirchBioMed Inc
    Bristol-Myers Squibb Company
    Ensemble Therapeutics Corp
    F. Hoffmann-La Roche Ltd
    Genentech Inc
    Globavir Biosciences Inc
    Incyte Corp
    IO Biotech ApS
    Kyowa Hakko Kirin
    Netherlands Translational Research Center BV
    NewLink Genetics Corp
    Pfizer Inc
    Redx Pharma Plc
    Regen BioPharma Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BMS-986205
    Dcellvax
    Epacadostat
    F-001287
    Galanal
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Aolpecia
    Cervical Cancer
    Gastric Cancer
    Glioma
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Indoleamine 2,3 Dioxygenase 1 Sales Market Report 2017
1 Indoleamine 2,3 Dioxygenase 1 Market Overview
    1.1 Product Overview and Scope of Indoleamine 2,3 Dioxygenase 1
    1.2 Classification of Indoleamine 2,3 Dioxygenase 1 by Product Category
        1.2.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Indoleamine 2,3 Dioxygenase 1 Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 BMS-986205
        1.2.4 Dcellvax
        1.2.5 Epacadostat
        1.2.6 F-001287
        1.2.7 Galanal
        1.2.8 Others
    1.3 Global Indoleamine 2,3 Dioxygenase 1 Market by Application/End Users
        1.3.1 Global Indoleamine 2,3 Dioxygenase 1 Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Aolpecia
        1.3.3 Cervical Cancer
        1.3.4 Gastric Cancer
        1.3.5 Glioma
        1.3.6 Others
    1.4 Global Indoleamine 2,3 Dioxygenase 1 Market by Region
        1.4.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
        1.4.3 China Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
        1.4.4 Europe Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
        1.4.5 Japan Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
        1.4.7 India Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Indoleamine 2,3 Dioxygenase 1 (2012-2022)
        1.5.1 Global Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2012-2022)
        1.5.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2012-2022)

2 Global Indoleamine 2,3 Dioxygenase 1 Competition by Players/Suppliers, Type and Application
     2.1 Global Indoleamine 2,3 Dioxygenase 1 Market Competition by Players/Suppliers
        2.1.1 Global Indoleamine 2,3 Dioxygenase 1 Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Indoleamine 2,3 Dioxygenase 1 (Volume and Value) by Type
        2.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Type (2012-2017)
        2.2.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Type (2012-2017)
    2.3 Global Indoleamine 2,3 Dioxygenase 1 (Volume and Value) by Region
        2.3.1 Global Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Region (2012-2017)
        2.3.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Region (2012-2017)
    2.4 Global Indoleamine 2,3 Dioxygenase 1 (Volume) by Application

3 United States Indoleamine 2,3 Dioxygenase 1 (Volume, Value and Sales Price)
    3.1 United States Indoleamine 2,3 Dioxygenase 1 Sales and Value (2012-2017)
        3.1.1 United States Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2012-2017)
        3.1.2 United States Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2012-2017)
        3.1.3 United States Indoleamine 2,3 Dioxygenase 1 Sales Price Trend (2012-2017)
    3.2 United States Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Players
    3.3 United States Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Type
    3.4 United States Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Application

4 China Indoleamine 2,3 Dioxygenase 1 (Volume, Value and Sales Price)
    4.1 China Indoleamine 2,3 Dioxygenase 1 Sales and Value (2012-2017)
        4.1.1 China Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2012-2017)
        4.1.2 China Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2012-2017)
        4.1.3 China Indoleamine 2,3 Dioxygenase 1 Sales Price Trend (2012-2017)
    4.2 China Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Players
    4.3 China Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Type
    4.4 China Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Application

5 Europe Indoleamine 2,3 Dioxygenase 1 (Volume, Value and Sales Price)
    5.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales and Value (2012-2017)
        5.1.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2012-2017)
        5.1.2 Europe Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Indoleamine 2,3 Dioxygenase 1 Sales Price Trend (2012-2017)
    5.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Players
    5.3 Europe Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Type
    5.4 Europe Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Application

6 Japan Indoleamine 2,3 Dioxygenase 1 (Volume, Value and Sales Price)
    6.1 Japan Indoleamine 2,3 Dioxygenase 1 Sales and Value (2012-2017)
        6.1.1 Japan Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2012-2017)
        6.1.2 Japan Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Indoleamine 2,3 Dioxygenase 1 Sales Price Trend (2012-2017)
    6.2 Japan Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Players
    6.3 Japan Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Type
    6.4 Japan Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Application

7 Southeast Asia Indoleamine 2,3 Dioxygenase 1 (Volume, Value and Sales Price)
    7.1 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales and Value (2012-2017)
        7.1.1 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales Price Trend (2012-2017)
    7.2 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Players
    7.3 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Type
    7.4 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Application

8 India Indoleamine 2,3 Dioxygenase 1 (Volume, Value and Sales Price)
    8.1 India Indoleamine 2,3 Dioxygenase 1 Sales and Value (2012-2017)
        8.1.1 India Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2012-2017)
        8.1.2 India Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2012-2017)
        8.1.3 India Indoleamine 2,3 Dioxygenase 1 Sales Price Trend (2012-2017)
    8.2 India Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Players
    8.3 India Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Type
    8.4 India Indoleamine 2,3 Dioxygenase 1 Sales Volume and Market Share by Application

9 Global Indoleamine 2,3 Dioxygenase 1 Players/Suppliers Profiles and Sales Data
    9.1 BirchBioMed Inc
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Bristol-Myers Squibb Company
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Ensemble Therapeutics Corp
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 F. Hoffmann-La Roche Ltd
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Genentech Inc
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Globavir Biosciences Inc
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Incyte Corp
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 IO Biotech ApS
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Kyowa Hakko Kirin
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Netherlands Translational Research Center BV
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 NewLink Genetics Corp
    9.12 Pfizer Inc
    9.13 Redx Pharma Plc
    9.14 Regen BioPharma Inc

10 Indoleamine 2,3 Dioxygenase 1 Maufacturing Cost Analysis
    10.1 Indoleamine 2,3 Dioxygenase 1 Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Indoleamine 2,3 Dioxygenase 1
    10.3 Manufacturing Process Analysis of Indoleamine 2,3 Dioxygenase 1

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Indoleamine 2,3 Dioxygenase 1 Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Indoleamine 2,3 Dioxygenase 1 Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Indoleamine 2,3 Dioxygenase 1 Market Forecast (2017-2022)
    14.1 Global Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Indoleamine 2,3 Dioxygenase 1 Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Indoleamine 2,3 Dioxygenase 1 Price and Trend Forecast (2017-2022)
    14.2 Global Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Type (2017-2022)
       14.3.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue Forecast by Type (2017-2022)
       14.3.3 Global Indoleamine 2,3 Dioxygenase 1 Price Forecast by Type (2017-2022)
    14.4 Global Indoleamine 2,3 Dioxygenase 1 Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion